l9n/ Pennsylvania

2017–2018 Regular Session

House Bill 2211

An Act providing for consumer prescription drug pricing disclosure.

Did not become law. It stopped in the Senate on September 26, 2018. The 2017–2018 session has ended.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

Its course

May 29 to September 26, 2018, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action15 actions on 6 days

In the House of RepresentativesMay 29 to Jun 2224 days

HealthMay 29 to Jun 1214 days

RulesJun 12 to Jun 219 days

AppropriationsJun 21 to Jun 221 day

In the SenateJun 22 to Sep 26 · stopped96 days

Banking & InsuranceJun 22 to Sep 2595 days

Votes

Yeas to nays, as the General Assembly recorded them. Committee votes are set in.

  • House of Representatives, third reading194–0

    Passed · Jun 22

Amendments

Each amendment offered, and what became of it.

  • House of Representatives committee amendmentAdopted

    Adopted Jun 12

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the House of Representatives May 29 – Jun 22

  1. Sent to HEALTH
  2. HEALTH recommended it as amended
  3. Sent to RULES
  4. RULES recommended it
  5. Read a second time
  6. Sent to APPROPRIATIONS
  7. APPROPRIATIONS recommended it
  8. Passed the House of Representatives, 194 to 0

In the Senate Jun 22 – Sep 26

  1. Arrived in the Senate
  2. Sent to BANKING AND INSURANCE
  3. BANKING AND INSURANCE recommended it
  4. Read a second time
All 15 actions, as published